Stryker's fourth-quarter results are expected to highlight resilient procedure volumes and strong capital demand, supported by product momentum and broad-based strength.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Besides Wall Street's top-and-bottom-line estimates for Stryker (SYK), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quar
Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bey Douglas LLC decreased its position in Stryker Corporation (NYSE: SYK) by 25.0% in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The institutional inve
Dynasty Wealth Management LLC lessened its position in shares of Stryker Corporation (NYSE: SYK) by 27.1% in the third quarter, according to the company in its most recent Form 13F filing with the Sec
Representative Thomas H. Kean, Jr. (R-New Jersey) recently bought shares of Liberty Media Corporation - Liberty Live Series C (NASDAQ: LLYVK). In a filing disclosed on January 16th, the Representative
Representative Thomas H. Kean, Jr. (R-New Jersey) recently bought shares of Liberty Media Corporation - Liberty Live Series A (NASDAQ: LLYVA). In a filing disclosed on January 16th, the Representative
Hologic and Stryker gear up for earnings with diagnostic wins, surgical growth and strategic moves shaping the medical device race.
Investors interested in Medical - Products stocks are likely familiar with Envista (NVST) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
Ferguson Wellman Capital Management Inc. boosted its holdings in shares of Stryker Corporation (NYSE: SYK) by 0.8% during the undefined quarter, according to the company in its most recent disclosure
Stryker offers above-average revenue growth, robust margin leverage, and a compelling valuation relative to med-tech peers despite sector-wide derating risks. Key growth drivers include Mako's continu
DSM Capital Partners LLC boosted its stake in shares of Stryker Corporation (NYSE: SYK) by 315.7% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchang
Cerity Partners LLC increased its holdings in Stryker Corporation (NYSE: SYK) by 1.1% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange
First Merchants Corp lowered its position in Stryker Corporation (NYSE: SYK) by 2.8% during the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The institu
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE